Residents of the Anderson area—when they paid with health insurance provided by an employer—spent 76 percent more on health care in 2009 than the average American with employer health insurance, highest among all metropolitan areas in the nation.
The hype over accountable care organizations—something every major hospital in Indianapolis is moving to become—is increasingly being laced with skepticism as the economics behind the idea get more scrutiny.
Indianapolis-based SynCare LLC has been touting its growth in Missouri since it entered the market in 2009. But now SynCare’s excursions in the show-me state have turned into a nightmare.
The decision last year by the U.S. Department of Health and Human Services not to exclude health insurance brokers commissions from a provision in the 2010 health reform law has been “devastating to brokers,” broker advocate Janet Trautwein said during an August speech in Fishers, and there are signs that Congress will act to reverse the policy.
The next four years could be rough for makers of medical devices and orthopedic implants, including Bloomington-based Cook Medical Inc. and Warsaw-based Zimmer Holding Inc. and Biomet Inc.—and not because of the 2010 health reform law.
Executives at Roche Diagnostics expect the wave of austerity measures being taken by western governments—including the United States—to as much as double its sales of fluid- and DNA-based tests in the next three years.
The Thomson Reuters study that showed Anderson as the highest-spending health care market in the nation also concluded that treatment and spending vary widely from one locale to another with no clear reason based on demographics or health outcomes.
Drugmakers including Eli Lilly an Co. have agreed with regulators on a 6-percent increase in review fees as part of reauthorizing the drug-approval process through fiscal 2017.
Indianapolis-based SynCare has ended its contract to screen Missouri Medicaid recipients after numerous complaints about its job performance.
Indianapolis-based SynCare LLC, hired to determine the eligibility of Missouri Medicaid patients for in-home care, has "been a complete disaster from the beginning," statewide health care advocates charge.
With hospitals having scooped up hundreds of physicians in the past three years—putting nearly all of them under non-compete agreements—there are bound to be legal tussles when some of those physicians decide their new matches aren’t exactly made in heaven.
As consumer-directed health plans become more prevalent, their power to save money for employers is waning, according to the latest survey by Indianapolis-based United Benefit Advisors.
Marian disclosed Evans’ 2010 donation Wednesday as it held a groundbreaking ceremony for its medical and nursing school building, which will be called the Michael A. Evans Center for Health Sciences.
Angela Smith, an attorney for hospitals and physicians at Indianapolis-based Hall Render Killian Heath & Lyman P.C., spoke about Medicare’s value-based purchasing program, a federal initiative that will attempt to shift health care payments from the fee-for-service model to one based on health outcomes. On July 1, hospitals began being scored on their performance in 13 categories, including processes, patient outcomes and patient satisfaction surveys. How hospitals score could boost or diminish all their Medicare payments by as much as 1 percent, beginning in October 2012.
New drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing systems.
Indianapolis doctor tell researchers that hospitals are paying more than $1 million a year to employ some cardiologists.
Eli Lilly and Co. spent $1.9 million lobbying the federal government in the first quarter, focusing on the health care overhaul and overseas pricing reform, among many other issues.
WellPoint lobbied on issues tied to the overhaul's implementation and regulations for accountable care organizations, which are networks of hospitals, doctors, rehabilitation centers and other providers that coordinate a patient's care.
Arcadia Resources Inc.’s share price dwindled to just 5 cents as of late Tuesday morning, following the company's announcement that it was delisting its stock and had suffered another quarterly loss.
